Search
Search Results
-
Cognitive impairment and neurocognitive profiles among people living with HIV and HIV-negative individuals older over 50 years: a comparison of IHDS, MMSE and MoCA
We aimed to examine the l differences in the assessment of neurocognitive impairment (NCI) using cognitive screening tools between PLWH and...
-
Cognitive impairment in people with epilepsy: Montreal Cognitive Assessment (MoCA) as a screening tool
ObjectivesAlthough cognitive impairment is common in people with epilepsy, it is often neglected in outpatient clinics. MoCA is a simple and reliable...
-
Resting-state networks and their relationship with MoCA performance in PD patients
Although mild cognitive impairment is a common non-motor symptom experienced by individuals with Parkinson’s Disease, the changes in intrinsic...
-
Validation of the Slovenian version of the Montreal Cognitive Assessment Scale as a screening tool for the detection of mild cognitive impairment
ObjectiveThe Montreal cognitive assessment scale (MoCA) is commonly used for detecting individuals with mild cognitive impairment (MCI). The aim of...
-
Effect of N-acetyltransferase 2 genetic polymorphism on 4,4′-methylenebis(2-chloroaniline)-induced genotoxicity and oxidative stress
4,4′-Methylenebis(2-chloroaniline) or MOCA is an aromatic amine used primarily in polyurethane and rubber industry. MOCA has been linked to hepatomas...
-
The validity of the Montreal cognitive assessment (MoCA) for the screening of vascular cognitive impairment after ischemic stroke
Vascular cognitive impairment (VCI) is a common feature of vascular brain lesions. The heterogeneity of clinical presentation after a stroke makes it...
-
Anodal HD-tDCS on the dominant anterior temporal lobe and dorsolateral prefrontal cortex: clinical results in patients with mild cognitive impairment
ObjectivesMild cognitive impairment (MCI) is a neurocognitive disorder in which the cognitive and mental abilities of humans are declined....
-
Resting-state EEG measures cognitive impairment in Parkinson’s disease
Cognitive dysfunction is common in Parkinson’s disease (PD). We developed and evaluated an EEG-based biomarker to index cognitive functions in PD...
-
Selective vulnerability of hippocampal sub-regions in patients with subcortical vascular mild cognitive impairment
Early diagnosis of subcortical vascular mild cognitive impairment (svMCI) is clinically essential because it is the most reversible subtype of all...
-
Effect of the Start Time of Cognitive Rehabilitation after Ischemic Stroke on the Level of Recovery
Objectives . To evaluate the results of cognitive rehabilitation carried out at different times after ischemic stroke (IS). Materials and methods . A...
-
Structural network disruption of corticothalamic pathways in cerebral small vessel disease
Generalized fractional anisotropy (GFA) can eliminate the crossing fiber effect, which may be more reflective of brain tissue changes in patients...
-
Serum level of YWHAG as a diagnostic marker of cognitive impairment in Parkinson’s disease patients
BackgroundIdentifying reliable biomarkers for early detection and prediction of cognitive impairment in Parkinson’s disease (PD) is crucial for...
-
Study of electronic biofeedback combined with nursing intervention in the treatment of vascular cognitive impairment-no dementia
ObjectiveTo investigate the effects of electronic biofeedback combined with nursing intervention and conventional drug treatment on cognitive...
-
Montreal Cognitive Assessment of cognitive dysfunction after basal ganglia stroke
ObjectiveThe Montreal Cognitive Assessment (MoCA) was used to evaluate cognitive dysfunction after basal ganglia stroke, and factors affecting total...
-
The Use of Mexidol in Patients with Mild (Moderate) Cognitive Impairment: Results of a Meta-Analysis
Objective . To conduct a meta-analysis of the efficacy of Mexidol therapy in patients with chronic cerebral ischemia (CCI) and mild (moderate)...
-
Rehabilitation of Patients with Post-Stroke Cognitive Impairments Using a P300-Based Brain–Computer Interface: Results of a Randomized Controlled Trial
Objective . To study the effects of 10 days of cognitive training using brain–computer interface (BCI) technology based on the P300 wave on the...
-
Montreal Cognitive Assessment (MoCA) for HIV-Associated Neurocognitive Disorders
This study aims to systematically review the evidence on the accuracy of the Montreal Cognitive Assessment (MoCA) test for diagnosing HIV–associated...
-
Improving cognitive function with intermittent dose escalation of curcumin extract in chemotherapy-induced cognitive impairment patients: a randomized controlled trial
Chemotherapy-induced cognitive impairment (CICI) is an impairment of memory, learning power, concentration, reasoning, executive function, attention,...
-
Free-water imaging reveals unique brain microstructural deficits in hispanic individuals with Dementia
Prior evidence suggests that Hispanic and non-Hispanic individuals differ in potential risk factors for the development of dementia. Here we...
-
The effects of exergames on upper extremity performance, trunk mobility, gait, balance, and cognition in Parkinson’s disease: a randomized controlled study
BackgroundIn recent years, game-based exercises have been included more in the rehabilitation programs of Parkinson’s disease (PD) patients and...
